In this focused issue, Global Trends in the Surgical Management of Gastric Cancer, we present original articles, reviews of literature and expert opinions by international experts covering a spectrum of key topics from changing guidelines in multimodality management, update on D2 lymphadenectomy, utility of enhanced recovery after surgery, technical considerations in robotic gastrectomy, and clinical trial outcomes. In sum, they provide insight into the concepts that are setting the global trends in GC care worldwide toward opti-mization of GC patient outcomes.
Clinical and molecular prognostic markers of survival after sur-gery for gastric cancer: tumor-node-metastasis staging system and beyond
Checkpoint inhibition in advanced gastroesophageal cancer: clini-cal trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapies
Assessment of body composition and impact of sarcopenia and sarcopenic obesity in patients with gastric cancer
Minimally invasive approaches for early gastric cancer in East Asia: current status and future perspective
Modular step-up approach to robot-assisted transthoracic esoph-agectomy—experience of a German high volume center
The series “Global Trends in The Surgical Management of Gastric Cancer” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Yanghee Woo, Taeil Son and Kazutaka Obama served as the unpaid Guest Editors for the series.